From MDS to AML: What Every Patient Needs to Know 11/28/17

From MDS to AML: Understanding the Pathology, Diagnostics, and Genetic Relationship 10/10/17Подробнее

MDS/AML Overlap and Novel Therapies with Dr. Naval DaverПодробнее

How likely is it for patients with MDS to transform to AML?Подробнее

Treatment Decision-Making through the Spectrum of MDSПодробнее

Precision Medicine in MDS and AMLПодробнее

Biology of AML Developing from MDS vs. de Novo AML, and New Targets for TherapyПодробнее

Resetting Standards in MDSПодробнее

Sabatolimab plus HMAs in patients with HR-MDS and AMLПодробнее

Expert Explains the Greatest Challenge in Treating Patients With MDS and AMLПодробнее

The MDS Patient Journey: A Snapshot of Short and Long Term Effects 5/18/17Подробнее

Factoring in Comorbidities in MDS Risk StratificationПодробнее

What can be done to treat AML if it doesn’t go into remission or comes back?Подробнее

Can early treatment for MDS prevent progression to AML? #AMLПодробнее

Expanding treatment options for AML to patients with MDSПодробнее

Epigenetic mechanisms driving the progression of MDS to secondary AMLПодробнее

Use of Molecular Genetic Testing in MDS and MPNПодробнее

Improving MDS management: new targets, drug combinations, and personalized and cellular therapiesПодробнее